Category - New Drugs
FDA Approves Nexlizet (bempedoic acid and ezetimibe) to Lower LDL-Cholesterol
Puma Biotechnology Receives U.S. FDA Approval of Supplemental New Drug Application for Neratinib to Treat HER2-Positive Metastatic Breast Cancer
FDA Approves Vyepti (eptinezumab-jjmr) Intravenous Injection for the Preventive Treatment of Migraine
FDA Approves Nexletol (bempedoic acid) to Lower LDL-Cholesterol
FDA Approves Anjeso (meloxicam injection) for the Management of Moderate to Severe Pain
Horizon Therapeutics plc Announces U.S. FDA Approval of New Dosage Form for Procysbi (Cysteamine Bitartrate) Delayed-Release Oral Granules
FDA Approves GSK’s Voltaren Arthritis Pain for Over-the-Counter Use in the United States
FDA Approves Twirla (levonorgestrel and ethinyl estradiol) Contraceptive Patch